The new product offering will supply global life science researchers with performance and reliability in multi-fragment ...
CHICAGO, IL / ACCESSWIRE / September 22, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative ...
The All Cosmos Bio-Tech EPS (TTM) is 2.04. All Cosmos Bio-Tech (4148) reported sales of 829.80, net income of 68.76, and EPS of 1.02 for the latest quarter. What was All Cosmos Bio-Tech's net income ...
ZURICH, ZURICH, SWITZERLAND, August 2, 2023/EINPresswire.com/ -- InSphero AG and Cosmo Bio Co., Ltd. are announcing a strategic partnership to distribute InSphero’s ...
Bio-Quant’s parent, NexMed, claims deal will provide formal presence in Japan and increase existing foothold. Japanese company Cosmo Bio negotiated distribution rights to Bio-Quant’s discovery and ...
Click the link below to download a spreadsheet with an example Market Cap calculation for All Cosmos Bio-Tech Holding Corp below: The chart above depicts the distribution of Market Cap for companies ...
Explore the TYO:3386 financials. Find the Cosmo Bio financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial ...
Japan Year Ended December 31 GROUP 2025 2024 Revenue Y10.77 bln Y10.04 bln Operating Profit Y343.00 mln Y318.00 mln Pretax Profit Y489.00 mln Y364.00 mln Net Profit Y337.00 mln Y262.00 mln Per share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results